ObsEva views Swiss IPO, trading debut this month

Source: Dukascopy Bank SA
ObsEva, the Swiss drug development firm, is planning a listing on the Zurich SIX Swiss Exchange and a trading debut scheduled for July 13, as it seeks expansion among EU investors.
Back to articles

Actual Topics

Fri, 06 Jul 2018 12:15:13 GMT

Italy's Cerved works on potential M&A deals

Marco Nespolo, the CEO of Italy's debt collector and data provider Cerved Group, stated his company is working on important mergers and acquisitions among the sectors where the firm already operates.

Fri, 06 Jul 2018 11:31:22 GMT

Praxair, Linde hope to seal their merger this year

Germany's industrial gases firm Linde and peer Praxair are seeking to sign a merger deal this year, after they had agreed to sell Praxair's EU gases business to Japan's competitor Taiyo Nippon Sanso.

Subscribe to "Fundamental Analysis" feed

Subscribe
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.